课题基金 / 基金详情

Diet and obesity influence immune checkpoint inhibitor efficacy in lung cancer

Diet and obesity influence immune checkpoint inhibitor efficacy in lung cancer
饮食和肥胖影响免疫检查点抑制剂对肺癌的疗效
批准号：
458818
负责人：
Desharnais Lysanne
金额：
$7.65万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458818&lang=en
关键词：
Diet Gut Microbiome Immune Checkpoint Inhibitor Inflammation Obesity Oncology

项目摘要

项目成果

Desharnais Lysanne的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Immune checkpoint inhibitors are a type of cancer therapy that targets your immune system's natural ability to fight cancer. This treatment has been revolutionary for lung cancer, which is often diagnosed late and is very deadly. However, only a minority
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of 2-hydroxyglutarate as a contributor to immune system evasion in cancer
  • 批准号：
    406300
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2018
  • 负责人：
    Desharnais Lysanne
  • 依托单位：
    McGill University
海外基金